Vitamin D Levels in Non-immediate Drug Hypersensitivity Case-control Study

A Study of Vitamin D Levels in Patients With Non-immediate Drug Hypersensitivity, Case-control Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06263140

Enrollment

120

Registered

2024-02-16

Start date

2021-05-30

Completion date

2022-02-01

Last updated

2024-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug-Induced Rash, Drug Reaction With Eosinophilia and Systemic Symptom, Maculopapular Exanthem, Stevens-Johnson Syndrome, Vitamin D Deficiency

Keywords

vitamin D, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptom, Maculopapular Exanthem, Drug Allergy, Drug Hypersensitivity

Brief summary

Serum vitamin D levels in drug-induced non-immediate reactions

Detailed description

The study of serum vitamin D levels in patients presented with drug-induced non-immediate cutaneous adverse reactions compared to those in drug-tolerant control subjects

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

15 Years to No maximum

Healthy volunteers

Inclusion criteria

* Diagnosed with SJS/TEN, DRESS, AGEP, MPE, or FDE as mentioned above

Exclusion criteria

* Reactions from drugs with known strong genetic predispositions (allopurinol, carbamazepine, abacavir) * Receiving vitamin D supplement

Design outcomes

Primary

Measure	Time frame	Description
Serum vitamin D levels	At baseline	Serum vitamin D levels at baseline

Countries

Thailand

Outcome results